Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Vertex Pharmaceuticals Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

80 comunicati stampa

Guarda tutti i comunicati
23/10/2026
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Oncologia
Web e Social Network
Eventi
Industria
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
20/10/2026
Biotecnologia
Salute
Scienza
Farmaceutica
Mercato del lavoro
Vertex Appoints Daniel Brennan to its Board of Directors
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
09/10/2026
Eventi
Industria
Scienza
Infanzia
Biotecnologia
Medicina - Varie
Sanità
Farmaceutica
Vetrine/Shopping
Salute
Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
07/10/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Salute
Scienza
Farmaceutica
Vertex to Announce Third Quarter 2026 Financial Results November 2nd
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
22/09/2026
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
15/09/2026
Medicina - Varie
Sport
Igiene alimentare
Sci - Sci alpinismo - Snowboard
Management
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Industria
Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
01/09/2026
Mercato del lavoro
Mercato azionario
Salute
Scienza
Medicina - Varie
Farmaceutica
Biotecnologia
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
26/08/2026
Web e Social Network
Eventi
Biotecnologia
Farmaceutica
Finanza
Oncologia
Salute
Banca
Associazioni/Professionisti
Medicina - Varie
Vertex to Participate in Upcoming September Investor Conferences
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
03/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Vertex Reports Second Quarter 2026 Financial Results
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0
07/07/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Vertex to Announce Second Quarter 2026 Financial Results on August 3rd
Fonte
Vertex Pharmaceuticals Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0